AVIENT CORPORATION (AVNT) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.26%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.26% | Share-based compensation / revenue. Period ending 2026-06-30. $8.60M ÷ $3.33B × 100 ≈ 0.26% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 3.33B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 8.60M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 314.90M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.33B | $8.60M | $314.90M | (m) | (m) | 0.26% | (m) | (m) |
| 2026-03-31 | (m) | $3.28B | $8.80M | $298.60M | (m) | (m) | 0.27% | (m) | (m) |
| 2025-12-31 | $96.70M | $3.26B | $9.10M | $203.50M | (m) | 2.97% | 0.28% | (m) | (m) |
| 2025-09-30 | (m) | $3.25B | $9.80M | $249.50M | (m) | (m) | 0.30% | (m) | (m) |
| 2025-06-30 | (m) | $3.25B | $11.00M | $259.60M | (m) | (m) | 0.34% | (m) | (m) |
| 2025-03-31 | (m) | $3.24B | $14.50M | $236.00M | (m) | (m) | 0.45% | (m) | (m) |
| 2024-12-31 | $98.70M | $3.24B | $15.40M | $329.30M | (m) | 3.05% | 0.48% | (m) | (m) |
| 2024-09-30 | (m) | $3.21B | $16.00M | $286.80M | (m) | (m) | 0.50% | (m) | (m) |
| 2024-06-30 | (m) | $3.15B | $15.70M | $243.90M | (m) | (m) | 0.50% | (m) | (m) |
| 2024-03-31 | (m) | $3.13B | $13.30M | $233.70M | (m) | (m) | 0.43% | (m) | (m) |
| 2023-12-31 | $90.30M | $3.14B | $13.20M | $196.80M | (m) | 2.87% | 0.42% | (m) | (m) |
| 2023-09-30 | (m) | $3.21B | $13.40M | $154.10M | (m) | (m) | 0.42% | (m) | (m) |
| 2023-06-30 | (m) | $3.28B | $13.40M | $160.40M | (m) | (m) | 0.41% | (m) | (m) |
| 2023-03-31 | (m) | $3.35B | $13.20M | $198.20M | (m) | (m) | 0.39% | (m) | (m) |
| 2022-12-31 | $84.90M | $3.40B | $13.20M | $243.30M | (m) | 2.50% | 0.39% | (m) | (m) |
| 2022-09-30 | (m) | $4.92B | $12.30M | $394.50M | (m) | (m) | 0.25% | (m) | (m) |
| 2022-06-30 | (m) | $5.02B | $11.90M | $410.80M | (m) | (m) | 0.24% | (m) | (m) |
| 2022-03-31 | (m) | $4.95B | $11.70M | $389.40M | (m) | (m) | 0.24% | (m) | (m) |
| 2021-12-31 | $83.20M | $4.82B | $11.20M | $381.20M | (m) | 1.73% | 0.23% | (m) | (m) |
| 2021-09-30 | (m) | $4.61B | $12.60M | $372.20M | (m) | (m) | 0.27% | (m) | (m) |
| 2021-06-30 | (m) | $4.32B | $11.20M | $327.00M | (m) | (m) | 0.26% | (m) | (m) |
| 2021-03-31 | (m) | $3.69B | $11.90M | $256.90M | (m) | (m) | 0.32% | (m) | (m) |
| 2020-12-31 | $59.80M | $3.24B | $11.30M | $189.30M | (m) | 1.84% | 0.35% | (m) | (m) |
| 2020-09-30 | (m) | $2.90B | $10.70M | $144.80M | (m) | (m) | 0.37% | (m) | (m) |
| 2020-06-30 | (m) | $2.68B | $12.30M | $154.40M | (m) | (m) | 0.46% | (m) | (m) |
| 2020-03-31 | (m) | $2.82B | $11.90M | $162.50M | (m) | (m) | 0.42% | (m) | (m) |
| 2019-12-31 | $50.60M | $2.86B | $12.30M | $156.80M | (m) | 1.77% | 0.43% | (m) | (m) |
| 2019-09-30 | (m) | $3.53B | $11.30M | $261.60M | (m) | (m) | 0.32% | (m) | (m) |
| 2019-06-30 | (m) | $3.52B | $11.10M | $257.40M | (m) | (m) | 0.32% | (m) | (m) |
| 2019-03-31 | (m) | $3.53B | $10.70M | $263.20M | (m) | (m) | 0.30% | (m) | (m) |
| 2018-12-31 | $56.30M | $3.53B | $10.90M | $273.70M | (m) | 1.59% | 0.31% | (m) | (m) |
| 2018-09-30 | (m) | (m) | $10.50M | $278.50M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $10.00M | $273.70M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | $10.50M | $274.30M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $52.10M | (m) | $10.20M | $277.50M | $60.80M | (m) | (m) | 4.56× | Reported |
| 2017-09-30 | (m) | (m) | $9.90M | $289.40M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $9.80M | $293.70M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $8.60M | $292.00M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $54.50M | (m) | $8.40M | $281.90M | $59.80M | (m) | (m) | 4.71× | Reported |
| 2016-09-30 | (m) | (m) | $9.60M | $255.30M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $9.20M | $253.30M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $9.40M | $252.10M | $62.60M | (m) | (m) | 4.03× | Reported |
| 2015-12-31 | $53.00M | (m) | $9.10M | $250.90M | $64.10M | (m) | (m) | 3.91× | Reported |
| 2015-09-30 | (m) | (m) | $8.80M | $205.30M | $64.10M | (m) | (m) | 3.20× | Reported |
| 2015-06-30 | (m) | (m) | $8.30M | $199.70M | $63.30M | (m) | (m) | 3.15× | Reported |
| 2015-03-31 | (m) | $3.71B | $12.30M | $168.80M | $62.80M | (m) | 0.33% | 2.69× | Reported |
| 2014-12-31 | $53.40M | $3.84B | $14.20M | $155.10M | $62.20M | 1.39% | 0.37% | 2.49× | Reported |
| 2014-09-30 | (m) | $3.89B | $14.70M | $218.10M | $61.90M | (m) | 0.38% | 3.52× | Reported |
| 2014-06-30 | (m) | $3.94B | $16.50M | $216.10M | $62.50M | (m) | 0.42% | 3.46× | Reported |
| 2014-03-31 | (m) | $3.97B | $13.30M | $247.40M | $63.40M | (m) | 0.33% | 3.90× | Reported |
| 2013-12-31 | $52.60M | $3.77B | $16.50M | $231.50M | $63.50M | 1.39% | 0.44% | 3.65× | Reported |
| 2013-09-30 | (m) | $3.50B | $15.80M | $196.10M | $61.90M | (m) | 0.45% | 3.17× | Reported |
| 2013-06-30 | (m) | $3.33B | $15.50M | $207.60M | $58.30M | (m) | 0.47% | 3.56× | Reported |
| 2013-03-31 | (m) | $3.05B | $15.40M | $170.20M | $54.10M | (m) | 0.51% | 3.15× | Reported |
| 2012-12-31 | $41.90M | $2.99B | $10.40M | $167.10M | $50.80M | 1.40% | 0.35% | 3.29× | Reported |
| 2012-09-30 | (m) | $2.95B | $9.20M | $108.60M | $45.60M | (m) | 0.31% | 2.38× | Reported |
| 2012-06-30 | (m) | $2.95B | $7.80M | $100.70M | $41.50M | (m) | 0.26% | 2.43× | Reported |
| 2012-03-31 | (m) | $2.93B | $6.20M | $98.10M | $37.50M | (m) | 0.21% | 2.62× | Reported |
| 2011-12-31 | $36.90M | $2.86B | $5.40M | $233.00M | $33.70M | 1.29% | 0.19% | 6.91× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $33.80M | $2.62B | $4.40M | $174.60M | $31.50M | 1.29% | 0.17% | 5.54× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $30.20M | $2.06B | $2.60M | $137.10M | $34.30M | 1.47% | 0.13% | 4.00× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROGERS CORP (ROG) | United States | $2.435B | -34.15 |
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| PureCycle Technologies, Inc. (PCT) | United States | $0.975B | -7.32 |
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |
| EASTMAN CHEMICAL CO (EMN) | United States | $7.575B | 17.34 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| DuPont de Nemours, Inc. (DD) | United States | $17.580B | 1,010.90 |
| DOW INC. (DOW) | United States | $20.577B | -11.55 |